Cancer & SURVIVEiT News

Category Filter:

FDA approves atezolizumab for BRAF V600 unresectable or metastatic melanoma

August 2, 2020

FDA approves atezolizumab for BRAF V600 unresectable or metastatic melanoma On July 30, 2020, the Food and Drug Administration approved atezolizumab (Tecentriq, Genentech, Inc.) in combination with cobimetinib and vemurafenib…

Immunotherapy Cancer Patient Story: Keeping a Positive Outlook When Melanoma Returned

June 18, 2020

During Cancer Immunotherapy Awareness Month, we want to share cancer patient stories and how they came to find immunotherapy as a treatment option. See how Summer’s positive outlook and support…

6 Warning Signs of Melanoma

May 22, 2020

Early detection is crucial when it comes to finding melanoma. In fact, according to the Skin Cancer Foundation, there is a 99% 5-year survival rate for patients in the U.S.…

Big News for BRAF-Mutant Melanoma Patients

May 8, 2020

An international trial was conducted that studied patients with previously untreated advanced BRAF-mutant melanoma to the doublet or triplet regimens. Here is an overview of the results. Triplet Succeeds in…

FDA approves first treatment for advanced form of the second most common skin cancer

October 3, 2018

FDA approves first treatment for advanced form of the second most common skin cancer New drug targets PD-1 pathway The U.S. Food and Drug Administration today approved Libtayo (cemiplimab-rwlc) injection…